S-warfarin limited sampling strategy with a population pharmacokinetic approach to estimate exposure and cytochrome P450 (CYP) 2C9 activity in healthy adults.
European journal of clinical pharmacology | 2021-09-01 | PMID 33754183
Tran Lana, Nikanjam Mina, Capparelli Edmund V and 5 more
